Price is the key in hepatitis C treatments directly sold from other countries

In the domestic hepatitis C treatment market, new drugs which were proved to have shorter treatment periods and less side effects have started to distinguish themselves one by one.

However, on the other side of all the differentiated advantages brought up by the new hepatitis C drugs, a disadvantage called ‘pricey drug’ can be found. While a number of expensive pharmaceutical products, such as...